{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:55:59Z","timestamp":1790837759266,"version":"4.1.0"},"reference-count":68,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>A central challenge in systemic sclerosis (SSc) is the inability to distinguish active, potentially reversible disease, from damage, irreversible fibrosis. Current imaging modalities, including high-resolution computed tomography (HRCT) and echocardiography, predominantly capture structural damage and cannot resolve this distinction. This review outlines next generation imaging modalities for SSc with focus on quantitative machine learning algorithms and molecular imaging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>The unifying advance across organ systems is a shift from documenting damage to measuring disease activity directly. Machine-learning-derived quantitative HRCT detects radiological patterns of ILD sensitive to change in SSc-associated interstitial lung disease. Parametric cardiac magnetic resonance mapping resolves diffuse interstitial fibrosis missed by late gadolinium enhancement. Fibroblast activation protein inhibitor PET (FAPI-PET) visualizes active fibrogenesis in lung and myocardium, identifying biologically active disease even before structural distortion occurs. [18F]Sodium fluoride PET detects metabolically active calcinosis. High-frequency ultrasound, elastography, and optical coherence tomography (OCT)-angiography extend objective assessment of cutaneous and microvascular involvement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Emerging imaging modalities in SSc may enable earlier detection of active disease amenable to treatment modification and yield more sensitive endpoints for SSc clinical trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bor.0000000000001182","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T10:00:32Z","timestamp":1786010432000},"page":"359-368","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Advanced imaging in systemic sclerosis: distinguishing activity from damage across organ systems"],"prefix":"10.1097","volume":"38","author":[{"given":"Alana","family":"Haussmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth R.","family":"Volkmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"R1-20261001","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0140-6736(22)01692-0","article-title":"Systemic sclerosis","volume":"401","author":"Volkmann","year":"2023","journal-title":"Lancet"},{"key":"R2-20261001","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s12931-025-03401-8","article-title":"A composite endpoint for systemic sclerosis-associated interstitial lung disease: association with mortality in two clinical trial cohorts","volume":"26","author":"Volkmann","year":"2025","journal-title":"Respir Res"},{"key":"R3-20261001","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/2397198318765061","article-title":"The challenges and controversies of measuring disease activity in systemic sclerosis","volume":"3","author":"Ross","year":"2018","journal-title":"J Scleroderma Relat Disord"},{"key":"R4-20261001","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"R5-20261001","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5301\/jsrd.5000231","article-title":"Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis","volume":"2","author":"Khanna","year":"2017","journal-title":"J Scleroderma Relat Disord"},{"key":"R6-20261001","doi-asserted-by":"crossref","first-page":"101668","DOI":"10.1016\/j.berh.2021.101668","article-title":"Cardiac involvement in systemic sclerosis: getting to the heart of the matter","volume":"35","author":"Bruni","year":"2021","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R7-20261001","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S2213-2600(20)30318-0","article-title":"Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"8","author":"Khanna","year":"2020","journal-title":"Lancet Respir Med"},{"key":"R8-20261001","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","article-title":"Nintedanib for systemic sclerosis-associated interstitial lung disease","volume":"380","author":"Distler","year":"2019","journal-title":"N Engl J Med"},{"key":"R9-20261001","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/annrheumdis-2018-213708","article-title":"Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts","volume":"78","author":"Volkmann","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"R10-20261001","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/annrheumdis-2020-217455","article-title":"Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database","volume":"80","author":"Hoffmann-Vold","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"R11-20261001","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/S2665-9913(19)30144-4","article-title":"The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements","volume":"2","author":"Hoffmann-Vold","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"R12-20261001","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1513\/AnnalsATS.201802-079OC","article-title":"Longitudinal changes in quantitative interstitial lung disease on computed tomography after immunosuppression in the Scleroderma Lung Study II","volume":"15","author":"Goldin","year":"2018","journal-title":"Ann Am Thorac Soc"},{"key":"R13-20261001","first-page":"S26","article-title":"A computer-aided diagnosis system for quantitative scoring of extent of lung fibrosis in scleroderma patients","volume":"28","author":"Kim","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"R14-20261001","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1002\/art.41668","article-title":"Tocilizumab prevents progression of early systemic sclerosis-associated interstitial lung disease","volume":"73","author":"Roofeh","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"R15-20261001","doi-asserted-by":"crossref","first-page":"2004503","DOI":"10.1183\/13993003.04503-2020","article-title":"Computed tomography-based radiomics decodes prognostic and molecular differences in interstitial lung disease related to systemic sclerosis","volume":"59","author":"Schniering","year":"2022","journal-title":"Eur Respir J"},{"key":"R16-20261001","doi-asserted-by":"crossref","first-page":"e475","DOI":"10.1016\/S2665-9913(21)00143-0","article-title":"Quantification of 68Ga-FAPI-04 in systemic sclerosis-associated interstitial lung disease","volume":"3","author":"Broens","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"R17-20261001","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1007\/s00259-025-07710-4","article-title":"Exploratory evaluation of early 68Ga-FAPI-46\u200aPET\/CT volume-based parameters in systemic sclerosis-associated interstitial lung disease","volume":"53","author":"Tai","year":"2026","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R18-20261001","doi-asserted-by":"crossref","first-page":"102598","DOI":"10.1016\/j.eclinm.2024.102598","article-title":"FAPi PET\/CT for assessment and visualisation of active myositis-related interstitial lung disease: a prospective observational pilot study","volume":"72","author":"Kastrati","year":"2024","journal-title":"EClinicalMedicine"},{"key":"R19-20261001","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.2967\/jnumed.124.268351","article-title":"Correlation of FAPI PET uptake with immunohistochemistry in explanted lungs from patients with advanced interstitial lung disease","volume":"65","author":"Hotta","year":"2024","journal-title":"J Nucl Med"},{"key":"R20-20261001","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1093\/rheumatology\/kep263","article-title":"Ultrasound lung comets in systemic sclerosis: a chest sonography hallmark of pulmonary interstitial fibrosis","volume":"48","author":"Gargani","year":"2009","journal-title":"Rheumatology"},{"key":"R21-20261001","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/acr.24338","article-title":"Development and assessment of novel lung ultrasound interpretation criteria for the detection of interstitial lung disease in systemic sclerosis","volume":"73","author":"Fairchild","year":"2021","journal-title":"Arthritis Care Res"},{"key":"R22-20261001","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1093\/rheumatology\/ker357","article-title":"The impact of cardiopulmonary manifestations on the mortality of SSc: a systematic review and meta-analysis of observational studies","volume":"51","author":"Kom\u00f3csi","year":"2012","journal-title":"Rheumatology"},{"key":"R23-20261001","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00296-015-3382-2","article-title":"Cardiac involvement in systemic sclerosis: differences between clinical subsets and influence on survival","volume":"37","author":"Fern\u00e1ndez-Codina","year":"2017","journal-title":"Rheumatol Int"},{"key":"R24-20261001","doi-asserted-by":"crossref","first-page":"e036730","DOI":"10.1161\/JAHA.124.036730","article-title":"Evaluation of systemic sclerosis primary heart involvement and chronic heart failure in the European scleroderma trials and research cohort","volume":"14","author":"Gy\u00f6rfi","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"R25-20261001","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/23971983211053246","article-title":"Primary systemic sclerosis heart involvement: a systematic literature review and preliminary data-driven, consensus-based WSF\/HFA definition","volume":"7","author":"Bruni","year":"2022","journal-title":"J Scleroderma Relat Disord"},{"key":"R26-20261001","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/ehjci\/jeac094","article-title":"Diffuse myocardial fibrosis precedes subclinical functional myocardial impairment and provides prognostic information in systemic sclerosis","volume":"24","author":"Gotschy","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"R27-20261001","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1093\/rheumatology\/keac098","article-title":"Cardiac magnetic resonance in systemic sclerosis myocarditis: the value of T2 mapping to detect myocardial inflammation","volume":"61","author":"De Luca","year":"2022","journal-title":"Rheumatology"},{"key":"R28-20261001","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1532-429X-16-21","article-title":"Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis\u2014a clinical study using myocardial T1-mapping and extracellular volume quantification","volume":"16","author":"Ntusi","year":"2014","journal-title":"J Cardiovasc Magn Reson"},{"key":"R29-20261001","doi-asserted-by":"crossref","first-page":"162.e1","DOI":"10.1016\/j.crad.2020.09.023","article-title":"Myocardial T1 mapping and extracellular volume quantification as novel biomarkers in risk stratification of patients with systemic sclerosis","volume":"76","author":"Bordonaro","year":"2021","journal-title":"Clin Radiol"},{"key":"R30-20261001","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1007\/s00259-022-06081-4","article-title":"Assessment of myocardial fibrosis in patients with systemic sclerosis using [68Ga]Ga-FAPI-04-PET-CT","volume":"50","author":"Treutlein","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R31-20261001","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/BOR.0000000000000896","article-title":"Calcinosis in systemic sclerosis","volume":"34","author":"Davuluri","year":"2022","journal-title":"Curr Opin Rheumatol"},{"key":"R32-20261001","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/BOR.0000000000000658","article-title":"Calcinosis in scleroderma made crystal clear","volume":"31","author":"Hsu","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"R33-20261001","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/art.1780270202","article-title":"Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis","volume":"27","author":"Steen","year":"1984","journal-title":"Arthritis Rheum"},{"key":"R34-20261001","doi-asserted-by":"crossref","first-page":"e22443","DOI":"10.1097\/MD.0000000000022443","article-title":"Relationship between calcifications and structural lesions on hand radiography and axial calcifications on CT-scan: a retrospective study in systemic sclerosis","volume":"99","author":"Bauer","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"R35-20261001","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/bjd.12785","article-title":"Plain radiography is effective for the detection of calcinosis cutis occurring in association with autoimmune connective tissue disease","volume":"170","author":"Shahi","year":"2014","journal-title":"Br J Dermatol"},{"key":"R36-20261001","doi-asserted-by":"crossref","first-page":"151980","DOI":"10.1016\/j.semarthrit.2022.151980","article-title":"Change in calcinosis over 1\u200ayear using the scleroderma clinical trials consortium radiologic scoring system for calcinosis of the hands in patients with systemic sclerosis","volume":"53","author":"Valenzuela","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"R37-20261001","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13075-020-02392-9","article-title":"Computer vision applied to dual-energy computed tomography images for precise calcinosis cutis quantification in patients with systemic sclerosis","volume":"23","author":"Chandrasekaran","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"R38-20261001","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keag302","article-title":"Scleroderma calcinosis cutis score (SC2S): an imaging metric to quantify systemic sclerosis-calcinosis cutis","volume":"65","author":"Odell","year":"2026","journal-title":"Rheumatology"},{"key":"R39-20261001","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10140-020-01785-2","article-title":"Dual energy CT in clinical routine: how it works and how it adds value","volume":"28","author":"Sodickson","year":"2021","journal-title":"Emerg Radiol"},{"key":"R40-20261001","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s10067-015-2998-7","article-title":"Use of dual-energy computed tomography for the evaluation of calcinosis in patients with systemic sclerosis","volume":"34","author":"Hsu","year":"2015","journal-title":"Clin Rheumatol"},{"key":"R41-20261001","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12969-025-01098-z","article-title":"Imaging assessment of calcinosis in juvenile dermatomyositis: a narrative review","volume":"23","author":"Yi","year":"2025","journal-title":"Pediatr Rheumatol"},{"key":"R42-20261001","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/acr.21668","article-title":"Ultrasonographic hand features in systemic sclerosis and correlates with clinical, biologic, and radiographic findings","volume":"64","author":"Elhai","year":"2012","journal-title":"Arthritis Care Res"},{"key":"R43-20261001","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.semnuclmed.2014.07.008","article-title":"Sodium 18F-fluoride PET\/CT of bone, joint and other disorders","volume":"45","author":"Jadvar","year":"2015","journal-title":"Semin Nucl Med"},{"key":"R44-20261001","doi-asserted-by":"crossref","first-page":"152027","DOI":"10.1016\/j.semarthrit.2022.152027","article-title":"[18F]Sodium fluoride PET has the potential to identify active formation of calcinosis cutis in limited cutaneous systemic sclerosis","volume":"55","author":"Atzeni","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"R45-20261001","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3899\/jrheum.200234","article-title":"High-frequency ultrasound assessment of systemic sclerosis skin involvement: intraobserver repeatability and relationship with clinician assessment and dermal collagen content","volume":"48","author":"Flower","year":"2021","journal-title":"J Rheumatol"},{"key":"R46-20261001","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/acr.23597","article-title":"Ultrasonography for the assessment of skin in systemic sclerosis: a systematic review","volume":"71","author":"Santiago","year":"2019","journal-title":"Arthritis Care Res"},{"key":"R47-20261001","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.3899\/jrheum.090974","article-title":"Ultrasound elastography assessment of skin involvement in systemic sclerosis: lights and shadows","volume":"37","author":"Iagnocco","year":"2010","journal-title":"J Rheumatol"},{"key":"R48-20261001","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/art.37988","article-title":"Review: evidence that systemic sclerosis is a vascular disease","volume":"65","author":"Matucci-Cerinic","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R49-20261001","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/BOR.0000000000000959","article-title":"Pathogenesis of vasculopathy in systemic sclerosis and its contribution to fibrosis","volume":"35","author":"Kawaguchi","year":"2023","journal-title":"Curr Opin Rheumatol"},{"key":"R50-20261001","doi-asserted-by":"crossref","first-page":"102458","DOI":"10.1016\/j.autrev.2020.102458","article-title":"Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis","volume":"19","author":"Smith","year":"2020","journal-title":"Autoimmun Rev"},{"key":"R51-20261001","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.ard.2025.11.021","article-title":"From the grey area of presystemic sclerosis to very early disease and irreversible tissue damage: the challenge of defining at-risk patients for future preventive trials in systemic sclerosis","volume":"85","author":"Lescoat","year":"2026","journal-title":"Ann Rheum Dis"},{"key":"R52-20261001","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s13075-020-02342-5","article-title":"High NEMO score values in nailfold videocapillaroscopy are associated with the subsequent development of ischaemic digital ulcers in patients with systemic sclerosis","volume":"22","author":"Del Papa","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"R53-20261001","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1186\/s13075-014-0462-8","article-title":"Nailfold videocapillaroscopy micro-haemorrhage and giant capillary counting as an accurate approach for a steady state definition of disease activity in systemic sclerosis","volume":"16","author":"Sambataro","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"R54-20261001","doi-asserted-by":"crossref","first-page":"67","DOI":"10.5114\/reum.2016.60215","article-title":"Capillaroscopy\u2013a role in modern rheumatology","volume":"54","author":"Chojnowski","year":"2016","journal-title":"Reumatologia"},{"key":"R55-20261001","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.1093\/rheumatology\/keab258","article-title":"Retinal microcirculation abnormalities in patients with systemic sclerosis: an explorative optical coherence tomography angiography study","volume":"60","author":"Carnevali","year":"2021","journal-title":"Rheumatology"},{"key":"R56-20261001","doi-asserted-by":"crossref","first-page":"101292","DOI":"10.1016\/j.preteyeres.2024.101292","article-title":"Optical coherence tomography angiography of the retina and choroid in systemic diseases","volume":"103","author":"Chua","year":"2024","journal-title":"Prog Retin Eye Res"},{"key":"R57-20261001","doi-asserted-by":"crossref","first-page":"198","DOI":"10.4078\/jrd.2024.0124","article-title":"The correlation between retinal microvascular changes by optical coherence tomography angiography and nailfold capillaroscopic findings in patients with systemic sclerosis","volume":"32","author":"Elsayed","year":"2025","journal-title":"J Rheum Dis"},{"key":"R58-20261001","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/BOR.0000000000000545","article-title":"Gastrointestinal involvement in systemic sclerosis: diagnosis and management","volume":"30","author":"McMahan","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"R59-20261001","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41584-023-00929-1","article-title":"Systemic sclerosis gastrointestinal dysmotility: risk factors, pathophysiology, diagnosis and management","volume":"19","author":"McMahan","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"R60-20261001","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1148\/rg.325115088","article-title":"Effectiveness of MR enterography for the assessment of small-bowel diseases beyond Crohn disease","volume":"32","author":"Amzallag-Bellenger","year":"2012","journal-title":"RadioGraphics"},{"key":"R61-20261001","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.crad.2021.04.014","article-title":"Multimodality imaging of the gastrointestinal manifestations of scleroderma","volume":"76","author":"Delaney","year":"2021","journal-title":"Clin Radiol"},{"key":"R62-20261001","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/nmo.12735","article-title":"Comparative quantitative assessment of global small bowel motility using magnetic resonance imaging in chronic intestinal pseudo-obstruction and healthy controls","volume":"28","author":"Menys","year":"2016","journal-title":"Neurogastroenterol Motil"},{"key":"R63-20261001","doi-asserted-by":"crossref","article-title":"Renal involvement in systemic sclerosis","author":"Scheen","DOI":"10.1016\/j.autrev.2023.103330"},{"key":"R64-20261001","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s12016-022-08945-x","article-title":"Renal disease and systemic sclerosis: an update on scleroderma renal crisis","volume":"64","author":"Cole","year":"2023","journal-title":"Clin Rev Allergy Immunol"},{"key":"R65-20261001","doi-asserted-by":"crossref","first-page":"ii4","DOI":"10.1093\/ndt\/gfy152","article-title":"Magnetic resonance imaging biomarkers for chronic kidney disease: a position paper from the European Cooperation in Science and Technology Action PARENCHIMA","volume":"33","author":"Selby","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"R66-20261001","doi-asserted-by":"crossref","first-page":"e70032","DOI":"10.1002\/acr2.70032","article-title":"Cerebrovascular involvement in systemic sclerosis","volume":"7","author":"Cutolo","year":"2025","journal-title":"ACR Open Rheumatol"},{"key":"R67-20261001","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","article-title":"Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration","volume":"12","author":"Wardlaw","year":"2013","journal-title":"Lancet Neurol"},{"key":"R68-20261001","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s40265-015-0534-3","article-title":"Management of neuropsychiatric systemic lupus erythematosus: current approaches and future perspectives","volume":"76","author":"Magro-Checa","year":"2016","journal-title":"Drugs"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/BOR.0000000000001182","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:01:44Z","timestamp":1790834504000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/BOR.0000000000001182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":68,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000001182","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]}}}